297 filings
Page 4 of 15
8-K
3cf2uma7scqjw
31 Jul 20
Regulation FD Disclosure
4:05pm
8-K
ftwhhywyq2tv0mweqtd
30 Jun 20
Entry into a Material Definitive Agreement
9:01am
8-K
kvccb
29 Jun 20
Acasti Pharma Provides Fiscal 2020 Year-End Business Update
12:50pm
8-K
z5elv8qji8faf71g 7oe
19 Jun 20
Acasti Pharma Receives FDA Response to TRILOGY 1 Briefing Package
9:09am
8-K
tjvndz
30 Apr 20
Acasti Pharma Announces Submission of TRILOGY 1 Briefing Package to FDA
4:22pm
8-K
3ofha3s07r3
20 Apr 20
Acasti Pharma Awarded Notice of Allowance for Second Composition of Matter Patent in Canada
4:05pm
8-K
egdfl vtt
1 Apr 20
Acasti Pharma Submits FDA Meeting Request on Schedule, and FDA Meeting Expected in the Second Half of June
5:12pm
6-K
fops8 yr5fvc3195udqi
11 Mar 20
Acasti Pharma Awarded Notice of Allowance for Additional Composition of Matter and Method of Use Patents in the United States and Mexico
8:00am
6-K
gojij3u toi5fsha
28 Feb 20
Acasti Receives NASDAQ Notification Regarding Minimum Bid Requirements
5:00pm
6-K
tud6a4e721q6hxt
14 Feb 20
Current report (foreign)
8:00am
6-K
3pgt30 0df9631
14 Feb 20
Acasti Pharma Provides Business Update for the Third Quarter of Fiscal 2020
8:00am
6-K
34ay082hhu q34k156
13 Feb 20
Acasti Pharma Schedules Third Quarter Fiscal 2020 and Business Update Conference Call
9:00am
6-K
vhc graa39b7jpu
10 Feb 20
Acasti Pharma Provides Update on TRILOGY 1 and TRILOGY 2 Phase 3 Trials of CaPre
7:00am
6-K
9n1jfkdzlt dek3m4c
13 Jan 20
Acasti Pharma Reports Topline Results for TRILOGY 1 Phase 3 Trial of CaPre
6:21am
6-K
glir 18p3u12
23 Dec 19
Acasti Pharma Provides Update on Timing of Topline Results for TRILOGY 1 Phase 3 Trial of CaPre
8:43pm
6-K
7g8fkpn9n68
26 Nov 19
Acasti Pharma Reports Last Patient Visit in TRILOGY 1 Phase 3 Trial of CaPre for the Treatment of Severe Hypertriglyceridemia
7:58am
6-K
r5asm398ga
18 Nov 19
Current report (foreign)
8:46am
6-K
mq6h3cq
13 Nov 19
Current report (foreign)
7:55am
6-K
b55h8w dj
13 Nov 19
Acasti Pharma Provides Business Update for the Second Quarter of Fiscal 2020
7:55am
6-K
b3ltvy
7 Nov 19
Acasti Pharma Announces Publication of CaPre Pharmacokinetics Study in a Leading Peer-Reviewed Journal
8:42am